| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-04-10 | STATE STREET CORP | Editas Medicine, Inc. | - | 10.7% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Editas Medicine, Inc. | 5,473,086 | 6.7% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Editas Medicine, Inc. | 8,461,701 | 10.4% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | Editas Medicine, Inc. | 7,838,969 | 9.6% | EDGAR |
| SC 13G/A | 2024-01-10 | STATE STREET CORP | Editas Medicine, Inc. | - | 6.2% | EDGAR |
| SC 13G | 2023-08-04 | Deep Track Capital, LP | Editas Medicine, Inc. | 4,493,416 | 5.5% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Editas Medicine, Inc. | 6,873,123 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-03 | STATE STREET CORP | Editas Medicine, Inc. | - | 13.4% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | Editas Medicine, Inc. | 7,338,742 | 10.7% | EDGAR |
| SC 13G/A | 2023-01-20 | BlackRock Inc. | Editas Medicine, Inc. | 7,338,742 | 10.7% | EDGAR |
| SC 13G/A | 2022-10-07 | BlackRock Inc. | Editas Medicine, Inc. | 6,982,775 | 10.2% | EDGAR |
| SC 13G/A | 2022-07-11 | STATE STREET CORP | Editas Medicine, Inc. | - | 11.5% | EDGAR |
| SC 13G/A | 2022-03-09 | VANGUARD GROUP INC | Editas Medicine, Inc. | 7,328,042 | 10.7% | EDGAR |
| SC 13G/A | 2022-02-14 | Nikko Asset Management Americas, Inc. | Editas Medicine, Inc. | 2,675,235 | 3.9% | EDGAR |
| SC 13G/A | 2022-02-09 | ARK Investment Management LLC | Editas Medicine, Inc. | 4,218,302 | 6.2% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | Editas Medicine, Inc. | 6,673,897 | 9.8% | EDGAR |
| SC 13G/A | 2022-02-04 | Sumitomo Mitsui Trust Holdings, Inc. | Editas Medicine, Inc. | 2,675,235 | 3.9% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Editas Medicine, Inc. | 5,433,376 | 7.9% | EDGAR |
| SC 13G/A | 2021-02-16 | ARK Investment Management LLC | Editas Medicine, Inc. | 10,125,564 | 16.2% | EDGAR |
| SC 13G/A | 2021-02-11 | Nikko Asset Management Americas, Inc. | Editas Medicine, Inc. | 4,388,143 | 7.0% | EDGAR |